Abstract:Objective: The dysfunction of the CLCN4 gene can lead to X-linked intellectual disability and Raynaud–Claes syndrome (MRXSRC), characterized by severe cognitive impairment and mental disorders. This study aimed to investigate the genetic defects and clinical features of Chinese children with CLCN4 variants and explore the effect of mutant ClC-4 on the protein expression level and subcellular localization through in vitro experiments. Methods: A total of 401 children with intellectual disabilities were screened for genetic variability using whole-exome sequencing (WES). Clinical data, including age, sex, perinatal conditions, and environmental exposure, were collected. Cognitive, verbal, motor, and social behavioral abilities were evaluated. Candidate variants were verified using Sanger sequencing, and their pathogenicity and conservation were analyzed using in silico prediction tools. Protein expression and localization of mutant ClC-4 were measured using Western blotting (WB) and immunofluorescence microscopy. The impact of a splice site variant was assessed with a minigene assay. Results: Exome analysis identified five rare CLCN4 variants in six unrelated patients with intellectual disabilities, including two recurrent heterozygous de novo missense variants (p.D89N and p.A555V) in three female patients, and two hemizygous missense variants (p.N141S and p.R694Q) and a splicing variant (c.1390-12T > G) that are maternally inherited in three male patients. The p.N141S variant and the splicing variant c.1390-12(T > G were novel, while p.R694Q was identified in two asymptomatic heterozygous female patients. The six children with CLCN4 variants exhibited a neurodevelopmental spectrum disease characterized by intellectual disability (ID), delayed speech, autism spectrum disorders (ASD), microcephaly, hypertonia, and abnormal imaging findings. The minigene splicing result indicated that the c.1390-12T > G did not affect the splicing of CLCN4 mRNA. In vitro experiments showed that the mutant protein level and localization of mutant protein are similar to the wild type. Conclusion: The study identified six probands with CLCN4 gene variants associated with X-linked ID. It expanded the gene and phenotype spectrum of CLCN4 variants. The bioinformatic analysis supported the pathogenicity of CLCN4 variants. However, these CLCN4 gene variants did not affect the ClC-4 expression levels and protein location, consistent with previous studies. Further investigations are necessary to investigate the pathogenetic mechanism.

Multiplex Consanguineous Family Highlights CLASP1 as a Candidate Gene for Lissencephaly

A variant suggests a phenotypic relation with lissencephaly in humans

[Molecular genetics of lissencephaly and microcephaly]

Unraveling LIS1-Lissencephaly: Insights from Cerebral Organoids Suggest Severity- Dependent Genotype-Phenotype Correlations, Molecular Mechanisms and Therapeutic Strategies

Bi-allelic CAMSAP1 variants cause a clinically recognizable neuronal migration disorder

Novel compound heterozygous GPR56 gene mutation in a twin with lissencephaly: A case report

Further characterization of CEP85L-associated lissencephaly type 10: Report of a three-generation family and review of the literature

Multiple dose-dependent effects of Lis1 on cerebral cortical development

Isolated Lissencephaly: Report of Four Patients From Two Unrelated Families

Causal heterogeneity in isolated lissencephaly

Human mutations in SLITRK3 implicated in GABAergic synapse development in mice

Novel compound heterozygous variants (c.971delA/c.542C > T) in SLC1A4 causes spastic tetraplegia, thin corpus callosum, and progressive microcephaly: a case report and mutational analysis

Brain Pathways in LIS1-Associated Lissencephaly Revealed by Diffusion MRI Tractography

Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy

Mutations in phospholipase C eta-1 (PLCH1) are associated with holoprosencephaly

Loss-of-function variant in the LRR domain of SLITRK2 implicated in a neurodevelopmental disorder

A founder PPIL1 variant underlies a recognizable form of microlissencephaly with pontocerebellar hypoplasia

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene

Increased LIS1 Expression Affects Human and Mouse Brain Development

Bi-allelic loss-of-function variants in BCAS3 cause a syndromic neurodevelopmental disorder

Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability